DAX24.894 +0,2%Est505.984 -0,5%MSCI World4.343 -0,1%Top 10 Crypto8,7800 +4,3%Nas22.595 ±-0,0%Bitcoin57.547 +3,2%Euro1,1862 -0,1%Öl67,61 +0,1%Gold5.008 +1,7%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
Siemens 723610 Deutsche Telekom 555750 Siemens Energy ENER6Y Rheinmetall 703000 SAP 716460 Amazon 906866 NVIDIA 918422 Mercedes-Benz Group (ex Daimler) 710000 Lufthansa 823212 BASF BASF11 Microsoft 870747 Heidelberg Materials 604700 Deutsche Bank 514000 DroneShield A2DMAA Allianz 840400
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
Nach US-Inflationsdaten: DAX stabil -- Wall Street im Minus -- Amazon im Bärenmarkt -- Delivery Hero, pbb, Siemens, RWE, Rivian, Applied Materials, Adyen, Apple, Arista im Fokus
Top News
Lufthansa-Aktie gewinnt: Nach Streiktag läuft Flugplan wieder planmäßig Lufthansa-Aktie gewinnt: Nach Streiktag läuft Flugplan wieder planmäßig
Safran begeistert mit dem 2026er Ausblick und erhöht die Guidance bis 2028. Die Aktie hebt zur Trendfolge ab! Safran begeistert mit dem 2026er Ausblick und erhöht die Guidance bis 2028. Die Aktie hebt zur Trendfolge ab!
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil

Altimmune Aktie

Kaufen
Verkaufen
Altimmune Aktien-Sparplan
3,95 EUR +0,13 EUR +3,38 %
STU
4,69 USD +0,14 USD +2,96 %
BTT
Altimmune jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

Marktkap.407,37 Mio. EUR

Div. Rendite0,00%
WKN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

WKNA2N5Z6

ISIN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

ISINUS02155H2004

Symbol wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

SymbolALT

Altimmune Aktien News

DatumMeistgelesen
BenzingaAltimmune (ALT) Shares Slide On $75 Million Stock Offering
BenzingaQorvo, Altimmune, United Microelectronics And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
BenzingaWhy Are Investors Looking At Altimmune Stock?
Wer­bungAltimmune-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero
BenzingaAltimmune, GH Research, Gyre Therapeutics And Other Big Stocks Moving Higher On Monday
ZacksDoes Altimmune (ALT) Have the Potential to Rally 229.28% as Wall Street Analysts Expect?
ZacksWall Street Analysts Predict a 250.59% Upside in Altimmune (ALT): Here's What You Should Know
BenzingaAltimmune Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)
PR NewswireALT Investors Have Opportunity to Lead Altimmune, Inc. Securities Fraud Lawsuit with the Schall Law Firm
PR NewswireINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Altimmune, Inc. of Class Action Lawsuit and Upcoming Deadlines - ALT
PR NewswireAltimmune, Inc. (NASDAQ: ALT) Deadline Approaching: Berger Montague Advises Investors of Deadline in Securities Fraud Lawsuit
PR NewswireALT Investors Have Opportunity to Lead Altimmune, Inc. Securities Fraud Lawsuit
PR NewswireINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Altimmune, Inc. of Class Action Lawsuit and Upcoming Deadlines - ALT
PR NewswireALT Investors Have Opportunity to Lead Altimmune, Inc. Securities Fraud Lawsuit with the Schall Law Firm
PR NewswireINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Altimmune, Inc. of Class Action Lawsuit and Upcoming Deadlines - ALT
PR NewswireINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Altimmune, Inc. of Class Action Lawsuit and Upcoming Deadlines - ALT
PR NewswireINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Altimmune, Inc. of Class Action Lawsuit and Upcoming Deadlines - ALT
PR NewswireINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Altimmune, Inc. of Class Action Lawsuit and Upcoming Deadlines - ALT
PR NewswireALT Investors Have Opportunity to Lead Altimmune, Inc. Securities Fraud Lawsuit with the Schall Law Firm
PR NewswireALT Investors Have Opportunity to Lead Altimmune, Inc. Securities Fraud Lawsuit
PR NewswireINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Altimmune, Inc. of Class Action Lawsuit and Upcoming Deadlines - ALT
PR NewswireINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Altimmune, Inc. of Class Action Lawsuit and Upcoming Deadlines - ALT
PR NewswireINVESTOR REMINDER: Berger Montague Notifies Altimmune, Inc. (NASDAQ: ALT) Investors of a Class Action Lawsuit and Deadline
PR NewswireINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Altimmune, Inc. - ALT
PR NewswireBerger Montague PC Investigates Securities Claims Against Altimmune, Inc. (NASDAQ: ALT)
BenzingaWhat 5 Analyst Ratings Have To Say About Altimmune
BenzingaThese Analysts Slash Their Forecasts On Altimmune Following Q2 Results
BenzingaAltimmune Q2 FY2025 Earnings Call Transcript
PR NewswireINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Altimmune, Inc. - ALT
PR NewswireALT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Altimmune, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
PR NewswireINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Altimmune, Inc. - ALT
PR NewswireINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Altimmune, Inc. - ALT
PR NewswireINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Altimmune, Inc. - ALT
ZacksAltimmune Gears Up to Report Q2 Earnings: Here's What to Expect
PR NewswireINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Altimmune, Inc. - ALT
PR NewswireINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Altimmune, Inc. - ALT
BenzingaAltimmune Stock Sinks After Mid-Stage Data From Fatty Liver Candidate
BenzingaAltimmune, Bit Digital, Kratos Defense & Security Solutions And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
BenzingaAltimmune (ALT) Stock Rises Amid Clinical Trial Progress: What's Going On?
ZacksHow Much Upside is Left in Altimmune (ALT)? Wall Street Analysts Think 285.86%
BenzingaWhat's Going On With Altimmune (ALT) Stock Today?

Altimmune News

Altimmune News: auf dieser Seite finden Sie alle Altimmune News und Nachrichten zur Altimmune Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Altimmune News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Altimmune News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.